Navigation Links
Nastech Appoints MDRNA, Inc. Directors Strategic Advisory Board
Date:2/5/2008

of Sterling Winthrop including marketing, strategic planning and general management, being appointed President of the U.S. Pharmaceutical business in 1993. Mr. Peters is a former Trustee and founding member of the Health Care Institute of New Jersey from 1996 to 2006; a former board member of the Pharmaceutical Research and Manufacturers of America from 1995 to 2005 and a former board member of the National Pharmaceutical Council from 1990 to 1993. Mr. Peters also served on the board of Diatide Inc. from 1994 to 1997. Mr. Peters holds a bachelors degree from Western Illinois University.

Steven C. Quay, M.D., Ph.D., has been employed by Nastech since August 2000 and currently serves as the Chairman of the Board and CEO. In 1999, Dr. Quay founded and was Chairman, President and CEO of Atossa Healthcare, Inc., which focused on the development of a proprietary platform of diagnostics and treatments related to breast cancer risk assessment and therapeutics and other healthcare products for women. Nastech acquired Atossa in August 2000. In 1991, Dr. Quay founded Sonus Pharmaceuticals, Inc., a company engaged in the research and development of drug delivery systems and oxygen delivery products based on emulsion and surfactant technology, where he served as CEO, President and a director until June 1999. In 1984, Dr. Quay founded Salutar, Inc. to develop contrast agents for magnetic resonance imaging. Two pharmaceuticals, OmniScan(R) and TeslaScan(R), were invented by Dr. Quay at Salutar and have been used in over 35 million patients since the drugs received regulatory approval. Dr. Quay has authored more than 100 papers in diagnostic imaging, oncology, RNA interference and biochemistry and holds 65 U.S. patents. Dr. Quay graduated from the University of Michigan Medical School, where he received an M.A. and a Ph.D. in biological chemistry in 1974 and 1975, respectively, and an M.D. in 1977. Dr. Quay completed his post-graduate work in the chemistry department of Mass
'/>"/>

SOURCE Nastech Pharmaceutical Company Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Nastech to Establish Subsidiary, MDRNA, Inc., as an Independent Company to Focus on the Development of RNA-Based Therapeutics
2. Nastech Pharmaceutical Company Initiates Plan for Corporate Restructuring and Will Concentrate on Phase 2 Clinical Programs
3. Nastech Pharmaceutical Company Announces the Jeffrey Wenig Memorial Award for Outstanding Achievement in Drug Delivery
4. Nastech Pharmaceutical Company Announces Promotion of Rick Costantino, Ph.D., to Chief Scientific Officer of Delivery
5. Milestone Scientific Appoints Dental Industry Veteran Scott Mahnken as New Director of Marketing
6. Skinvisible Appoints New Board Member
7. Tigris Pharmaceuticals Appoints Pedro Granadillo to Board of Directors
8. Neurochem appoints Mr. Gary Schmid as CEO of new nutraceutical business
9. Crdentia Appoints Charlie Mayhone to Director of Operations for its National Travel Division and Charlotte, North Carolina Market
10. National Institutes of Health Appoints Timothy C. Birdsall, ND to CAM Advisory Council
11. CPF Appoints Mishka Michon Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... ... August 04, 2015 , ... Patients are ... offered by the world renowned Beverly Hills facelift surgeon , Dr. Paul ... surgery techniques helps individuals to achieve an outer appearance that meets their personal ...
(Date:8/4/2015)... & LAS VEGAS (PRWEB) , ... August 04, 2015 , ... ... the pitch schedule for vendor participating in The ISE® Lions’ Den and Jungle Lounge ... Spa at Aria in Las Vegas. , During the event, eight emerging security vendors, ...
(Date:8/4/2015)... Las Vegas, Nevada (PRWEB) , ... August 04, ... ... INTIMATELY FEMALE, a striking contemporary look at unique artistic expressions from a diverse ... Motel inside the Life Is Beautiful Music & Art Festival on September 25-27, ...
(Date:8/4/2015)... ... 04, 2015 , ... Data2Life , a Tel Aviv-based ... provide pharmaceutical and healthcare organizations with advanced intelligence on drug effects. The product ... filings (including the FDA and HealthCanada), social media and anonymized clinical electronic health ...
(Date:8/4/2015)... ... 2015 , ... METTLER TOLEDO has announced an upcoming online ... Lubrizol, Pfizer, and Merck. This free online seminar will be held on ... require informed decisions with limited process understanding. Established methods have been developed ...
Breaking Medicine News(10 mins):Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 2Health News:Beverly Hills Surgeon, Dr. Paul Nassif, is Now Offering Personal Consultations with Full Examinations for Facial Plastic Surgeries 3Health News:T.E.N. Releases Pitch Schedule for The ISE® Lions Den & Jungle Lounge 2015 2Health News:T.E.N. Releases Pitch Schedule for The ISE® Lions Den & Jungle Lounge 2015 3Health News:T.E.N. Releases Pitch Schedule for The ISE® Lions Den & Jungle Lounge 2015 4Health News:Sin City Gallery Rocks Life Is Beautiful Festival with INTIMATELY FEMALE at Art Motel 2Health News:Sin City Gallery Rocks Life Is Beautiful Festival with INTIMATELY FEMALE at Art Motel 3Health News:Sin City Gallery Rocks Life Is Beautiful Festival with INTIMATELY FEMALE at Art Motel 4Health News:Data2Life Announces New System for Advance Intelligence on Drug Events 2Health News:Data2Life Announces New System for Advance Intelligence on Drug Events 3Health News:METTLER TOLEDO Announces New Process Chemistry and Scale-up Online Seminar 2
... STANFORD, Calif. The immune system may play a critical ... therapies, according to a new study by researchers at the ... disable cancer-promoting genes called oncogenes are much more successful in ... by kind of immune cell called a T helper cell. ...
... improved planning of care and stronger relationships with physicians ... to a study by a Queen,s University professor. , ... every Canadian," says professor of Medicine and Epidemiology Daren ... Hospital. "But it,s not always happening. We know from ...
... (HealthDay News) -- Treatments designed to tackle childhood obesity ... education programs are as effective as those that enlist ... parent-only programs are also generally cheaper and more practical ... the parent-only group was not inferior in terms of ...
... Reporter , TUESDAY, Oct. 26 (HealthDay News) -- As ... prevented if people followed five simple healthy lifestyle recommendations, ... improve overall health as well -- include exercise, a ... healthy weight, the researchers say. "Even a modest ...
... to hormonal changes and inflammation has been awarded a ... study. The research programme at the National Institute ... led by Professor Julian Davis, a consultant endocrinologist at ... Manchester,s Developmental Biomedicine Research Group. He is working ...
... Wu has invented a portable scanner based on radio frequency technology, ... tumours malignant and benign in the breast on a ... detection has been proven by researchers in the US, Canada and ... for an image to be produced, and this had to be ...
Cached Medicine News:Health News:Certain cancer therapies' success depends on presence of immune cell, Stanford study shows in mice 2Health News:Certain cancer therapies' success depends on presence of immune cell, Stanford study shows in mice 3Health News:Certain cancer therapies' success depends on presence of immune cell, Stanford study shows in mice 4Health News:Parent-Only Programs Can Help Obese Kids Lose Weight: Study 2Health News: Healthy Living Can Prevent Nearly 25% of Colorectal Cancers 2Health News: Healthy Living Can Prevent Nearly 25% of Colorectal Cancers 3Health News:Manchester team wins $1.9 million grant for 'cell control' study 2Health News:Portable breast scanner allows cancer detection in the blink of an eye 2
(Date:8/3/2015)... DRRX ) announced today financial results for the second ... loss was $5.5 million for the three months ended June ... and net loss of $5.5 million for the three months ... and investments of $37.8 million, compared to cash and investments ... 2015, we had $19.8 million in long term debt. ...
(Date:8/3/2015)... PARSIPPANY, N.J. , Aug. 3, 2015  LEO ... and Drug Administration (FDA) to include psoriasis as one ... Focused Drug Development Initiative i .  Psoriasis is an ... lives and subsequent comorbidities, affecting 7.5 million people in ... of LEO Pharma,s ongoing commitment to supporting patients living ...
(Date:8/3/2015)... N.Y. , Aug. 3, 2015 ... Wilmot Cancer Institute to the OmniSeq SM ... Roswell Park Cancer Institute (RPCI) and announced it ... that support a physician-driven, collaborative approach to genomic ... outcomes.  Wilmot Cancer Institute is a rapidly expanding, ...
Breaking Medicine Technology:DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 2DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 3DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 4DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 5DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 6DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 7DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 8DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 9DURECT Corporation Announces Second Quarter 2015 Financial Results and Update of Programs 10LEO Pharma Supports the FDA's Selection of Psoriasis as a Priority Disease 2LEO Pharma Supports the FDA's Selection of Psoriasis as a Priority Disease 3OmniSeq Adds Wilmot Cancer Institute to its Collaboration-Based Treatment Network 2OmniSeq Adds Wilmot Cancer Institute to its Collaboration-Based Treatment Network 3
... Researchers at Brigham and Women,s,Hospital found that patients taking ... effects were unrelated to relief from their pain,symptoms. ... examine the addictive,potential of this class of pain medicine, ... 25th Annual Meeting. , In ...
... Lethal ,Super, Strains of C.difficileCHICAGO, Jan. 28 ... scientists at The University of Nottingham are leading a ... one of the most lethal strains of hospital acquired ... technology developed in Nottingham to study the function of ...
Cached Medicine Technology:Study of Cannabinoid Medicine for Pain Found Patients Got 'High,' but Effects Not Related to Pain Relief 2British Midlands University Announces Use of Gene Technology to Fight Lethal Hospital Acquired Infection 2British Midlands University Announces Use of Gene Technology to Fight Lethal Hospital Acquired Infection 3
... Designed specifically to ... interventionalists, Sequitor facilitates the ... the peripheral vasculature for ... both uterine fibroid embolization ...
Reference Lab Interface (RLI)© for SRS Software, provides real-time processing of HL7 lab data directly into SRS Freedom Chart ManagerTM, producing an HTML form in the patients chart/tab, whil...
... technology innovation, the new Guidant VASOVIEW® 7 ... the VASOVIEW® platform. The new VASOVIEW® 7 ... familiar platform, combining ease of use with ... finesse into a proven system. Discover advanced ...
Patient Monitor...
Medicine Products: